Commerce Bank Supernus Pharmaceuticals, Inc. Transaction History

Commerce Bank

$15.3 Billion
Q2 2024

A detailed history of Commerce Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Commerce Bank holds 13,835 shares of SUPN stock, worth $442,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,835

Previous 13,835 -0.0%

Holding current value

$442,720

Previous $471,000 21.44%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$27.11 - $35.17 $13,826 - $17,936	-510 Reduced 3.56%	13,835 $471,000
Q4 2023 Feb 09, 2024	SELL	$22.72 - $29.68 $3,907 - $5,104	-172 Reduced 1.18%	14,345 $415,000
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $5,734 - $6,845	-208 Reduced 1.41%	14,517 $400,000
Q2 2023 Aug 08, 2023	SELL	$29.91 - $38.73 $5,234 - $6,777	-175 Reduced 1.17%	14,725 $442,000
Q1 2023 May 04, 2023	SELL	$34.93 - $42.03 $20,084 - $24,167	-575 Reduced 3.72%	14,900 $539,000
Q4 2022 Feb 10, 2023	SELL	$31.09 - $37.88 $131,666 - $160,421	-4,235 Reduced 21.49%	15,475 $551,000
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $23,235 - $26,813	-815 Reduced 3.97%	19,710 $637,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $79,901 - $103,686	3,030 Added 17.32%	20,525 $598,000
Q3 2021 Nov 09, 2021	SELL	$23.54 - $31.39 $31,072 - $41,434	-1,320 Reduced 7.02%	17,495 $466,000
Q2 2021 Aug 09, 2021	SELL	$26.72 - $33.19 $1,603 - $1,991	-60 Reduced 0.32%	18,815 $579,000
Q1 2021 May 05, 2021	BUY	$24.15 - $31.45 $133,308 - $173,604	5,520 Added 41.33%	18,875 $494,000
Q4 2020 Feb 09, 2021	SELL	$17.7 - $25.81 $3,186 - $4,645	-180 Reduced 1.33%	13,355 $336,000
Q3 2020 Nov 06, 2020	BUY	$20.2 - $25.05 $81,709 - $101,327	4,045 Added 42.62%	13,535 $282,000
Q2 2020 Aug 07, 2020	BUY	$17.09 - $24.89 $162,184 - $236,206	9,490 New	9,490 $225,000

Others Institutions Holding SUPN

# of Institutions

255

Shares Held

59.2M

Call Options Held

47.9K

Put Options Held

13.1K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.71B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account